Your browser doesn't support javascript.
loading
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.
Amir, Carolyn M; Kapler, Simon; Hoftman, Gil D; Kushan, Leila; Zinberg, Jamie; Cadenhead, Kristin S; Kennedy, Leda; Cornblatt, Barbara A; Keshavan, Matcheri; Mathalon, Daniel H; Perkins, Diana O; Stone, William; Tsuang, Ming T; Walker, Elaine F; Woods, Scott W; Cannon, Tyrone D; Addington, Jean; Bearden, Carrie E.
Affiliation
  • Amir CM; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Kapler S; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Hoftman GD; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Kushan L; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Zinberg J; Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Cadenhead KS; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States.
  • Kennedy L; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States.
  • Cornblatt BA; Department of Psychiatry, Zucker Hillside Hospital, Long Island, NY, United States.
  • Keshavan M; Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Boston, MA, United States.
  • Mathalon DH; Department of Psychiatry, San Francisco Veterans Affairs (SFVA) Medical Center, University of California, San Francisco (UCSF), San Francisco, CA, United States.
  • Perkins DO; Department of Psychiatry, University of North Carolina, Chapel Hill, NC, United States.
  • Stone W; Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, Boston, MA, United States.
  • Tsuang MT; Department of Psychiatry, University of California, San Diego (UCSD), San Diego, CA, United States.
  • Walker EF; Institute of Genomic Medicine, University of California, San Diego, La Jolla, CA, United States.
  • Woods SW; Departments of Psychology and Psychiatry, Emory University, Atlanta, GA, United States.
  • Cannon TD; Department of Psychiatry, Yale University, New Haven, CT, United States.
  • Addington J; Department of Psychology, Yale University, New Haven, CT, United States.
  • Bearden CE; Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Front Psychiatry ; 14: 1143315, 2023.
Article in En | MEDLINE | ID: mdl-37151981
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Front Psychiatry Year: 2023 Type: Article Affiliation country: United States